New nursing model aims to ease anxiety and pain in lung cancer patients
NCT ID NCT07525908
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a 4-week nursing program based on self-efficacy theory for 300 lung cancer patients receiving CyberKnife radiation. The program included education, psychological support, and self-management training. Researchers measured changes in anxiety, pain, and quality of life compared to standard nursing care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Self-Efficacy Theory-Based Nursing Model (behavioral intervention)
- What this could lead to
- If successful, this nursing model could offer a simple, drug-free way to help lung cancer patients feel less anxious, have less pain, and enjoy a better quality of life during treatment.
- What could go wrong
- This is a completed study with 300 participants, but it only tested a behavioral program, not a new drug or cure. The results may not apply to all lung cancer patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a VR headset calm nerves before surgery?
- Nature as therapy? a new trial tests outdoor outings for anxious kids
- Can a new drug combo revive Immunotherapy's power against resistant tumors?